Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China flag China · Delayed Price · Currency is CNY
10.18
-0.52 (-4.86%)
Aug 8, 2025, 1:45 PM CST

Changzhou Qianhong Biopharma CO.,LTD Company Description

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China.

The company offers its products in the form of tablets, hard capsules, lyophilized powder and lyophilized powder injections, small-volume injections, and raw materials.

It provides enzymes, including pancreatic kininogenase series, asparaginase series, and compound digestive enzyme capsule II; and polysaccharides products, such as nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium.

The company also offers nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium injections.

In addition, it exports its products. The company was founded in 1971 and is headquartered in Changzhou, China.

Changzhou Qianhong Biopharma CO.,LTD
CountryChina
Founded1971
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees979
CEOKe Wang

Contact Details

Address:
Life and Health Industrial Park
Changzhou, 213125
China
Phone86 519 8515 6003
Websiteqhsh.com.cn

Stock Details

Ticker Symbol002550
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100001070
SIC Code2836

Key Executives

NamePosition
Ke WangGM and Non-Independent Director
Yi YaoChief Financial Officer and Board Secretary
Xiang ZhouDeputy GM and Non-Independent Director
Lijun WeiChief Engineer and Director
Chizhou JiangNon-Independent Director and Deputy GM
Aiqun XiaoAudit Director
Juanwei HuaDeputy Director of Project Implementation Office and Non-Employee Supervisor